Posted February 5, 2021
Despite positive data, mainstream medicine is ignoring an affordable COVID medicine. Action Alert!   The Frontline COVID-19 Critical Care Alliance (FLCCC) published a paper reviewing the evidence for ivermectin, an off-patent drug for river blindness, arguing that it has antiviral and anti-inflammatory properties that make it effective in the prevention and treatment of COVID. The evidence on ivermectin is, unsurprisingly, being ignored by the medical establishment because it is a cheap drug and can’t make boatloads of money for drug companies—much like hydroxychloroquine. This is another example of what is wrong with American medicine; we must fight to change it.  Read more.